The fifth Covid-19 vaccine candidate has made its way into late-stage clinical trials in Western countries. Elizabeth Warren tells Elon Musk she's 'happy' to work with him on DOGE's goals to slash ...

The new COVID-19 vaccine rolled out across the country last month, giving people access to the most recent versions of the Moderna, Pfizer, and Novavax shots. But, given that you have options, which ...

It’s fall, which means it’s time to get updated on the winter season shots. That includes vaccines for flu, RSV (for babies and the elderly) and, for anyone six months or older, COVID-19. While the ...

The latest COVID vaccine set to hit the market - Novavax. The Maryland-based biotech company behind it says it's 100% effective against the original coronavirus and 93% effective against COVID ...

Vaccine maker Novavax says its shot is highly effective against COVID-19 and also protects against variants. The Maryland-based company on Monday announced results from a large, late-stage study in ...

Although Pfizer's and Moderna’s COVID-19 vaccines have been stealing the spotlight for years, some people are actively seeking out the lesser-known Novavax for their updated booster this fall.

Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well — against new mutated ...

WASHINGTON (Reuters) - A new kind of influenza vaccine works against the new swine flu virus in animals, Novavax Inc reported on Tuesday. The company said it made the vaccine, which uses so-called ...

Novavax announced Thursday that its COVID-19 vaccine proved safe and effective in a study of 12- to 17-year-olds. Novavax makes a protein-based vaccine — a different type than the most widely used ...

Investors with a lot of money to spend have taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the trades showed up on publicly available ...